-
公开(公告)号:US20100196466A1
公开(公告)日:2010-08-05
申请号:US12696666
申请日:2010-01-29
申请人: S. Rao CHERUKURI
发明人: S. Rao CHERUKURI
IPC分类号: A61K9/48 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/554 , A61K31/4422 , A61K31/4525 , A61K31/135 , A61K31/55 , A61K31/422 , A61K31/437 , A61K31/5517 , A61K31/415 , A61P29/00 , A61P1/10 , A61P1/06 , A61P1/04
摘要: A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided.
摘要翻译: 提供了一种新颖的包封产品,包括:至少一种药物; 至少一种可压缩材料; 和至少一个压片材料; 其中所述封装的产品为直径为约1毫米至约7毫米,长度为约1毫米至约7毫米的囊片形式。 还提供了一种制备包封产品的方法。
-
公开(公告)号:US20090136550A1
公开(公告)日:2009-05-28
申请号:US12272421
申请日:2008-11-17
IPC分类号: A61K9/48 , A61K31/554 , A61K9/14
CPC分类号: A61K31/55 , A61K9/2866 , A61K9/5047
摘要: Modified release diltiazem compositions and associated methods of preparation and administration are provided.
摘要翻译: 提供了改良释放的地尔硫卓组合物和相关的制备和给药方法。
-
公开(公告)号:US20140099378A1
公开(公告)日:2014-04-10
申请号:US13648991
申请日:2012-10-10
IPC分类号: A61K9/14 , A61K9/00 , A61P1/04 , A61K31/196
CPC分类号: A61K9/5078 , A61K9/2081 , A61K9/209 , A61K9/5026 , A61K9/5047 , A61K31/196
摘要: Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®.
摘要翻译: 公开和描述了含有美沙拉嗪化合物和相关方法的改性或延长释放制剂。 在一些方面,这样的制剂可以与已知的FDA批准的美沙拉胺制剂如PENTASA基本上是生物等效的。
-
公开(公告)号:US07678387B2
公开(公告)日:2010-03-16
申请号:US09982093
申请日:2001-10-19
申请人: S. Rao Cherukuri
发明人: S. Rao Cherukuri
CPC分类号: A23G3/36 , A21D13/80 , A23G3/343 , A23G3/346 , A23G3/362 , A23G3/368 , A23G3/54 , A23G4/06 , A23G4/064 , A23G4/126 , A23G4/20 , A23G2200/00 , A23G2200/04 , A23G2220/20 , A23L2/395 , A23L27/72 , A61J3/10 , A61K9/2018 , A61K9/2072
摘要: A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided.
摘要翻译: 提供了一种新颖的包封产品,包括:至少一种药物; 至少一种可压缩材料; 和至少一个压片材料; 其中所述封装的产品为直径为约1毫米至约7毫米,长度为约1毫米至约7毫米的囊片形式。 还提供了一种制备包封产品的方法。
-
公开(公告)号:US20100010101A1
公开(公告)日:2010-01-14
申请号:US12501652
申请日:2009-07-13
申请人: S. Rao Cherukuri
发明人: S. Rao Cherukuri
CPC分类号: A61K9/0056 , A61K9/1617 , A61K9/1641 , A61K9/1664 , A61K9/1694 , A61K9/2013 , A61K9/2031 , A61K9/2068 , A61K9/2095 , A61K31/09 , A61K31/137 , A61K31/351 , A61K31/375 , A61K31/60 , A61K31/726
摘要: The present invention provides a novel rapid-melt pharmaceutical composition comprising a binder, a super emulsifier, a diluent/bulking material; and an active ingredient. The present invention also provides a rapid-melt bead composition comprising a binder having a melting point from about 20 to about 90° C., an emulsifier; a diluent/bulking material; and an active ingredient. Further, the present invention provides a chew tablet composition comprising a binder; an emulsifier having a melting point of greater than about 40° C.; a diluent/bulking material; and an active ingredient. Methods of making the disclosed compositions are also described.
摘要翻译: 本发明提供一种新型的快速熔融药物组合物,其包含粘合剂,超级乳化剂,稀释剂/填充材料; 和活性成分。 本发明还提供一种包含熔点约20-90℃的粘合剂的快速熔融珠组合物,一种乳化剂; 稀释剂/膨胀材料; 和活性成分。 此外,本发明提供一种包含粘合剂的咀嚼片组合物; 具有大于约40℃的熔点的乳化剂; 稀释剂/膨胀材料; 和活性成分。 还描述了制备所公开的组合物的方法。
-
公开(公告)号:US20090017110A1
公开(公告)日:2009-01-15
申请号:US12049213
申请日:2008-03-14
IPC分类号: A61K9/48 , A61K31/196 , A61K9/20 , A61K9/00
CPC分类号: A61K9/1647 , A61K9/5047 , A61K9/5078 , A61K31/196
摘要: Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®.
摘要翻译: 公开和描述了含有美沙拉嗪化合物和相关方法的改性或延长释放制剂。 在一些方面,这些制剂可以与已知的FDA批准的美沙拉胺制剂如PENTASA基本上是生物等效的。
-
公开(公告)号:US20090311317A1
公开(公告)日:2009-12-17
申请号:US12466359
申请日:2009-05-14
IPC分类号: A61K9/54 , A61K31/137 , A61P25/00
CPC分类号: A61K31/137 , A61K9/1623 , A61K9/1652 , A61K9/1694 , A61K9/2095 , A61K9/5026
摘要: Modified or extended release formulations containing tolterodine and associated methods are disclosed and described. Methods for making and administering said modified release formulations are also disclosed.
摘要翻译: 公开和描述了含有托特罗定和相关方法的改性或延长释放制剂。 还公开了制备和施用所述改性释放制剂的方法。
-
公开(公告)号:US20090130208A1
公开(公告)日:2009-05-21
申请号:US12275634
申请日:2008-11-21
CPC分类号: A61K9/2077 , A61K9/2846 , A61K9/2866
摘要: Modified release niacin formulations, methods for making the formulations, and methods of using the formulations.
摘要翻译: 改性释放烟酸配制剂,制备制剂的方法和使用制剂的方法。
-
公开(公告)号:US20080014268A1
公开(公告)日:2008-01-17
申请号:US11819326
申请日:2007-06-26
申请人: Subraman Cherukuri
发明人: Subraman Cherukuri
CPC分类号: A61K9/2086 , A61K9/0056
摘要: The present invention is directed to multi-layered compositions for oral administration having at least one orally disintegrating layer and capable of maintaining layer cohesion. The present invention is also directed to methods of manufacturing such compositions.
摘要翻译: 本发明涉及具有至少一个口腔崩解层并能够保持层内聚力的口服多层组合物。 本发明还涉及制造这种组合物的方法。
-
公开(公告)号:US20080008742A1
公开(公告)日:2008-01-10
申请号:US11819902
申请日:2007-06-29
申请人: Subraman Cherukuri
发明人: Subraman Cherukuri
CPC分类号: A61K9/0056 , A61K9/0058
摘要: Methods for producing chewable emulsion compositions and compositions produced from such methods are disclosed. The emulsion base may be prepared by contacting an aqueous phase and a nonaqueous phase in the presence of an emulsifier. The aqueous phase is prepared under conditions that permit no substantial moisture loss and reduced viscosity. The methods permit preparing chewable compositions for delivering confectionary items, nutriceuticals, vitamins, minerals and therapeutically active agents. The compositions may be sugar-free or sugar-containing. The active agent may be added to the emulsion base at a lower temperature compared to the temperature at which either the aqueous or nonaqueous phase is formed. The compositions may be further coated with taste-masking materials, enteric coating materials, or slow-release materials. The compositions may be formed into compressible tablets, beads, granules, or otherwise generally known dosage forms.
摘要翻译: 公开了生产可咀嚼乳液组合物的方法和由这些方法制备的组合物。 乳液基质可以通过在乳化剂存在下使水相和非水相接触来制备。 水相在不允许大量水分损失和降低粘度的条件下制备。 该方法允许制备用于递送糖果物品,营养物质,维生素,矿物质和治疗活性剂的咀嚼组合物。 组合物可以是无糖或含糖的。 与形成水相或非水相的温度相比,活性剂可以在较低温度下加入到乳液基质中。 组合物可以进一步用味道掩蔽材料,肠溶衣材料或缓释材料涂覆。 组合物可形成可压片,珠粒,颗粒或其他通常已知的剂型。
-
-
-
-
-
-
-
-
-